BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate

Molecular and Cellular Biology

Volumn 26, Issue 14, 2006, Pages 5348-5359

  Juszczynski, Przemyslaw ^a   Kutok, Jeffery L ^b   Li, Cheng ^c   Mitra, Joydeep ^a   Aguiar, Ricardo C T ^a,d   Shipp, Margaret A ^a,d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; GAMMA INTERFERON; GENE PRODUCT; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; JANUS KINASE 2; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN BAL1; PROTEIN BBAP; STAT PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B CELL LYMPHOMA; BAL1 GENE; BBAP GENE; CELL STRAIN COS7; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CHROMOSOME 3Q; CONTROLLED STUDY; DENDRITIC CELL; FLUORESCENCE MICROSCOPY; GENE; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INFLAMMATORY INFILTRATE; LARGE CELL LYMPHOMA; MICROARRAY ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; TUMOR ASSOCIATED LEUKOCYTE;

BASE SEQUENCE; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 3; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON TYPE II; INTERFERON-GAMMA, RECOMBINANT; JANUS KINASE 2; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MUTATION; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SUBCELLULAR FRACTIONS; UBIQUITIN-PROTEIN LIGASES;

EID: 33745848147     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.02351-05     Document Type: Article

References (39)

1. Abramson, J. S., and M. A. Shipp. 2005. Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach. Blood 106:1164-1174.
2. Abu-Shaar, M., H. D. Ryoo, and R. S. Mann. 1999. Control of the nuclear localization of Extradenticle by competing nuclear import and export signals. Genes Dev. 13:935-945.
3. Aguiar, R. C., K. Takeyama, C. He, K. Kreinbrink, and M. A. Shipp. 2005. B-aggressive lymphoma family proteins have unique domains that modulate transcription and exhibit poly(ADP-ribose) polymerase activity. J. Biol. Chem. 280:33756-33765.
4. Aguiar, R. C., Y. Yakushijin, S. Kharbanda, R. Salgia, J. A. Fletcher, and M. A. Shipp. 2000. BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration. Blood 96:4328-4334.
5. Albig, W., P. Kioschis, A. Poustka, K. Meergans, and D. Doenecke. 1997. Human histone gene organization: nonregular arrangement within a large cluster. Genomics 40:314-322.
6. Angelov, D., A. Molla, P. Y. Perche, F. Hans, J. Cote, S. Khochbin, P. Bouvet, and S. Dimitrov. 2003. The histone variant macroH2A interferes with transcription factor binding and SWI/SNF nucleosome remodeling. Mol. Cell 11:1033-1041.
7. Boyd, S. D., K. Y. Tsai, and T. Jacks. 2000. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat. Cell Biol. 2:563-568.
8. Chow, W. A., J. J. Fang, and J. K. Yee. 2000. The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells. J. Immunol. 164:3512-3518.
9. Costanzi, C., and J. R. Pehrson. 1998. Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature 393:599-601.
10. Davuluri, R. V., I. Grosse, and M. Q. Zhang. 2001. Computational identification of promoters and first exons in the human genome. Nat. Genet. 29:412-417.
11. de Fries, R. U., and S. H. Golub. 1988. Characteristics and mechanism of IFN-gamma-induced protection of human tumor cells from lysis by lymphokine-activated killer cells. J. Immunol. 140:3686-3693.
12. De Vos, J., M. Jourdan, K. Tarte, C. Jasmin, and B. Klein. 2000. JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells. Br. J. Haematol. 109:823-828.
13. Dighe, A. S., E. Richards, L. J. Old, and R. D. Schreiber. 1994. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity 1:447-456.
14. Dovhey, S. E., N. S. Ghosh, and K. L. Wright. 2000. Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line. Cancer Res. 60:5789-5796.
15. Dunn, G. P., A. T. Bruce, K. C. Sheehan, V. Shankaran, R. Uppaluri, J. D. Bui, M. S. Diamond, C. M. Koebel, C. Arthur, J. M. White, and R. D. Schreiber. 2005. A critical function for type I interferons in cancer immunoediting. Nat. Immunol. 6:722-729.
16. Dunn, G. P., L. J. Old, and R. D. Schreiber. 2004. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137-148.
17. Fabbro, M., and B. R. Henderson. 2003. Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp. Cell Res. 282:59-69.
18. Fabbro, M., S. Schuechner, W. W. Au, and B. R. Henderson. 2004. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention. Exp. Cell Res. 298:661-673.
19. Galea, M. A., A. Eleftheriou, and B. R. Henderson. 2001. ARM domain-dependent nuclear import of adenomatous polyposis coli protein is stimulated by the B56 alpha subunit of protein phosphatase 2A. J. Biol. Chem. 276:45833-45839.
20. Geyer, R. K., Z. K. Yu, and C. G. Maki. 2000. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat. Cell Biol. 2:569-573.
21. Guarguaglini, G., A. Battistoni, C. Pittoggi, G. Di Matteo, B. Di Fiore, and P. Lavia. 1997. Expression of the murine RanBP1 and Htf9-c genes is regulated from a shared bidirectional promoter during cell cycle progression. Biochem. J. 325:277-286.
22. Huang, X. L., R. Pawliczak, X. L. Yao, M. J. Cowan, M. T. Gladwin, M. J. Walter, M. J. Holtzman, P. Madara, C. Logun, and J. H. Shelhamer. 2003. Interferon-gamma induces p11 gene and protein expression in human epithelial cells through interferon-gamma-activated sequences in the p11 promoter. J. Biol. Chem. 278:9298-9308.
23. Kaplan, D. H., V. Shankaran, A. S. Dighe, E. Stockert, M. Aguet, L. J. Old, and R. D. Schreiber. 1998. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95:7556-7561.
24. Li, C., and W. H. Wong. 2001. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA 98:31-36.
25. Loots, G. G., and I. Ovcharenko. 2004. rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res. 32:W217-W221.
26. Malmberg, K. J., V. Levitsky, H. Norell, C. T. de Matos, M. Carlsten, K. Schedvins, H. Rabbani, A. Moretta, K. Soderstrom, J. Levitskaya, and R. Kicssling. 2002. IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. J. Clin. Investig. 110:1515-1523.
27. Monti, S., K. J. Savage, J. L. Kutok, F. Feuerhake, P. Kurtin, M. Mihm, B. Wu, L. Pasqualucci, D. Neuberg, R. C. Aguiar, P. Dal Cin, C. Ladd, G. S. Pinkus, G. Salles, N. L. Harris, R. Dalla-Favera, T. M. Habermann, J. C. Aster, T. R. Golub, and M. A. Shipp. 2005. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 105:1851-1861.
28. Perche, P. Y., C. Vourc'h, L. Konecny, C. Souchier, M. Robert-Nicoud, S. Dimitrov, and S. Khochbin. 2000. Higher concentrations of histone macroH2A in the Barr body are correlated with higher nucleosome density. Curr. Biol. 10:1531-1534.
29. Sandelin, A., W. W. Wasserman, and B. Lenhard. 2004. ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res. 32:W249-W252.
30. Scherf, M., A. Klingenhoff, and T. Werner. 2000. Highly specific localization of promoter regions in large genomic sequences by Promoterlnspector: a novel context analysis approach. J. Mol. Biol. 297:599-606.
31. Shankaran, V., H. Ikeda, A. T. Bruce, J. M. White, P. E. Swanson, L. J. Old, and R. D. Schreiber. 2001. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410:1107-1111.
32. Street, S. E. A., E. Cretney, and M. J. Smyth. 2001. Perform and interferon-γ activities independently control tumor initiation, growth, and metastasis. Blood 97:192-197.
33. Street, S. E. A., J. A. Trapani, D. MacGregor, and M. J. Smyth. 2002. Suppression of lymphoma and epithelial malignancies effected by interferon γ. J. Exp. Med. 196:129-134.
34. Takeyama, K., R. C. Aguiar, L. Gu, C. He, G. J. Freeman, J. L. Kutok, J. C. Aster, and M. A. Shipp. 2003. The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activity. J. Biol. Chem. 278:21930-21937.
35. Tomita, Y., H. Watanabe, H. Kobayashi, T. Nishiyama, S. Tsuji, M. Fujiwara, and S. Sato. 1992. Interferon gamma but not tumor necrosis factor alpha decreases susceptibility of human renal cell cancer cell lines to lymphokine-activated killer cells. Cancer Immunol. Immunother. 35:381-387.
36. Trinklein, N. D., S. F. Aldred, S. J. Hartman, D. I. Schroeder, R. P. Otillar, and R. M. Myers. 2004. An abundance of bidirectional promoters in the human genome. Genome Res. 14:62-66.
37. Wright, G., B. Tan, A. Rosenwald, E. H. Hurt, A. Wiestner, and L. M. Staudt. 2003. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc. Natl. Acad. Sci. USA 100:9991-9996.
38. Xu, Y., and E. C. Uberbacher. 1997. Automated gene identification in large-scale genomic sequences. J. Comput. Biol. 4:325-338.
39. Yuan, B., R. Latek, M. Hossbach, T. Tuschl, and F. Lewitter. 2004. siRNA Selection Server: an automated siRNA oligonuclcotide prediction server. Nucleic Acids Res. 32:W130-W134.